Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Diamondcutter who wrote (3774)	5/1/1998 5:09:00 PM
From: LoLoLoLita	Read Replies (2) \| Respond to of 7041

>>The only thing of value one can add here is whether Vasomax >>works or not and will the NDA be approved. Diamondcutter, It won't be approved unless it's proved both safe and effective. Regitine is available from Ciba-Geigy as an (expensive) injectable, and phentolamine USP is available by the gram from Sigma-Aldrich, RBI, etc. It's an easy experiment. I'm quite puzzled that no one here seems to have tried it. Judgements as to the safety of the proposed self-referential experiment would seem to be well within the sphere of discretion routinely exercised by physicians who prescribe off-label medications. Blood pressure could be taken before the experiment to ensure that hypotension was not present. Any adverse hypotensive effects from the medication would likely be short-lived. David

To: Diamondcutter who wrote (3774)	5/1/1998 6:56:00 PM
From: Linda Kaplan	Respond to of 7041

Well, that's not entirely correct. For even if Vasomax were approved, what would the earnings be? Let's say they undercut the price of the Viagra pill, as was said a long while back by some of the longs. So they charge $5 a pill and they get, what? 20%? That is $1 a pill and they have cost of production and cost of running the company. They do spend money and judging from Vivus, the costs and problems involved in manufacture can be quite surprisingly high. I don't think they'll have an approved drug, but if they did, I don't know that they could make much money. Linda

To: Diamondcutter who wrote (3774)	5/1/1998 9:48:00 PM
From: Michael	Read Replies (2) \| Respond to of 7041

<<If you are going to make a public accusation that "shills" are fraudulently pumping up the stock, >> I did not say shills were fraudulently pumping up the stock. You are saying that. <<earnings or cash flow before the main product is launched is meaningless. >> AS always and as I expect the "shills" refuse even to give an estimate of expected revenues or earnings, Same Tired Old Hype. Just a different stock. <<you should know your credibility is minimized by asking uninformed questions. >> This is very typical of shills, just attack someone's credibility, just because I asked a question about expected revenues and earnings. Your Friend, Michael